FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110920739> ?p ?o ?g. }

• W2110920739 endingPage "1187" @default.
• W2110920739 startingPage "1179" @default.
• W2110920739 abstract "The renin-angiotensin-aldosterone system is involved in the arterial hypertension-associated cardiovascular remodeling. In this context, the development of cardiac fibrosis results from an imbalance between profibrotic and antifibrotic pathways, in which the role of aldosterone is yet not established. To determine the role of intracardiac aldosterone in the development of myocardial fibrosis during hypertension, we used a double transgenic model (AS-Ren) of cardiac hyperaldosteronism (AS) and systemic hypertension (Ren). The 9-month–old hypertensive mice had cardiac fibrosis, and hyperaldosteronism enhanced the fibrotic level. The mRNA levels of connective tissue growth factor and transforming growth factor-β1 were similarly increased in Ren and AS-Ren mice compared with wild-type and AS mice, respectively. Hyperaldosteronism combined with hypertension favored the macrophage infiltration (CD68 + cells) in heart, and enhanced the mRNA level of monocyte chemoattractant protein 1, osteopontin, and galectin 3. Interestingly, in AS-Ren mice the hypertension-induced increase in bone morphogenetic protein 4 mRNA and protein levels was significantly inhibited, and B-type natriuretic peptide expression was blunted. The mineralocorticoid receptor antagonist eplerenone restored B-type natriuretic peptide and bone morphogenetic protein 4 levels and decreased CD68 and galectin 3 levels in AS-Ren mice. Finally, when hypertension was induced by angiotensin II infusion in wild-type and AS mice, the mRNA profiles did not differ from those observed in Ren and AS-Ren mice, respectively. The aldosterone-induced inhibition of B-type natriuretic peptide and bone morphogenetic protein 4 expression was confirmed in vitro in neonatal mouse cardiomyocytes. Altogether, we demonstrate that, at the cardiac level, hyperaldosteronism worsens hypertension-induced fibrosis through 2 mineralocorticoid receptor-dependent mechanisms, activation of inflammation/galectin 3–induced fibrosis and inhibition of antifibrotic factors (B-type natriuretic peptide and bone morphogenetic protein 4)." @default.
• W2110920739 created "2016-06-24" @default.
• W2110920739 creator A5005197027 @default.
• W2110920739 creator A5006316949 @default.
• W2110920739 creator A5016214270 @default.
• W2110920739 creator A5017917935 @default.
• W2110920739 creator A5043563400 @default.
• W2110920739 creator A5045422208 @default.
• W2110920739 creator A5054480556 @default.
• W2110920739 creator A5054514406 @default.
• W2110920739 creator A5063733940 @default.
• W2110920739 creator A5072426509 @default.
• W2110920739 creator A5077167531 @default.
• W2110920739 creator A5082113937 @default.
• W2110920739 date "2012-06-01" @default.
• W2110920739 modified "2023-10-18" @default.
• W2110920739 title "Aldosterone Inhibits Antifibrotic Factors in Mouse Hypertensive Heart" @default.
• W2110920739 cites W1597133347 @default.
• W2110920739 cites W1993345123 @default.
• W2110920739 cites W1999792045 @default.
• W2110920739 cites W2000314258 @default.
• W2110920739 cites W2018299587 @default.
• W2110920739 cites W2024491849 @default.
• W2110920739 cites W2035653659 @default.
• W2110920739 cites W2038197919 @default.
• W2110920739 cites W2046204080 @default.
• W2110920739 cites W2048228600 @default.
• W2110920739 cites W2049491194 @default.
• W2110920739 cites W2050346306 @default.
• W2110920739 cites W2053634335 @default.
• W2110920739 cites W2065171831 @default.
• W2110920739 cites W2070109516 @default.
• W2110920739 cites W2076365943 @default.
• W2110920739 cites W2094651478 @default.
• W2110920739 cites W2100346820 @default.
• W2110920739 cites W2101551652 @default.
• W2110920739 cites W2102041759 @default.
• W2110920739 cites W2102815431 @default.
• W2110920739 cites W2106015949 @default.
• W2110920739 cites W2123248199 @default.
• W2110920739 cites W2123801122 @default.
• W2110920739 cites W2125948158 @default.
• W2110920739 cites W2136541388 @default.
• W2110920739 cites W2136718447 @default.
• W2110920739 cites W2140739392 @default.
• W2110920739 cites W2142604754 @default.
• W2110920739 cites W2143403693 @default.
• W2110920739 cites W2145495388 @default.
• W2110920739 cites W2150621532 @default.
• W2110920739 cites W2168588787 @default.
• W2110920739 cites W2547469502 @default.
• W2110920739 doi "https://doi.org/10.1161/hypertensionaha.111.190512" @default.
• W2110920739 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22547442" @default.
• W2110920739 hasPublicationYear "2012" @default.
• W2110920739 type Work @default.
• W2110920739 sameAs 2110920739 @default.
• W2110920739 citedByCount "75" @default.
• W2110920739 countsByYear W21109207392012 @default.
• W2110920739 countsByYear W21109207392013 @default.
• W2110920739 countsByYear W21109207392014 @default.
• W2110920739 countsByYear W21109207392015 @default.
• W2110920739 countsByYear W21109207392016 @default.
• W2110920739 countsByYear W21109207392017 @default.
• W2110920739 countsByYear W21109207392018 @default.
• W2110920739 countsByYear W21109207392019 @default.
• W2110920739 countsByYear W21109207392021 @default.
• W2110920739 countsByYear W21109207392022 @default.
• W2110920739 countsByYear W21109207392023 @default.
• W2110920739 crossrefType "journal-article" @default.
• W2110920739 hasAuthorship W2110920739A5005197027 @default.
• W2110920739 hasAuthorship W2110920739A5006316949 @default.
• W2110920739 hasAuthorship W2110920739A5016214270 @default.
• W2110920739 hasAuthorship W2110920739A5017917935 @default.
• W2110920739 hasAuthorship W2110920739A5043563400 @default.
• W2110920739 hasAuthorship W2110920739A5045422208 @default.
• W2110920739 hasAuthorship W2110920739A5054480556 @default.
• W2110920739 hasAuthorship W2110920739A5054514406 @default.
• W2110920739 hasAuthorship W2110920739A5063733940 @default.
• W2110920739 hasAuthorship W2110920739A5072426509 @default.
• W2110920739 hasAuthorship W2110920739A5077167531 @default.
• W2110920739 hasAuthorship W2110920739A5082113937 @default.
• W2110920739 hasBestOaLocation W21109207391 @default.
• W2110920739 hasConcept C126322002 @default.
• W2110920739 hasConcept C134018914 @default.
• W2110920739 hasConcept C170493617 @default.
• W2110920739 hasConcept C198710026 @default.
• W2110920739 hasConcept C2775915353 @default.
• W2110920739 hasConcept C2776069600 @default.
• W2110920739 hasConcept C2776292634 @default.
• W2110920739 hasConcept C2777420927 @default.
• W2110920739 hasConcept C2778198053 @default.
• W2110920739 hasConcept C2778525890 @default.
• W2110920739 hasConcept C2780559512 @default.
• W2110920739 hasConcept C2908929049 @default.
• W2110920739 hasConcept C71924100 @default.
• W2110920739 hasConcept C84393581 @default.
• W2110920739 hasConceptScore W2110920739C126322002 @default.
• W2110920739 hasConceptScore W2110920739C134018914 @default.

• next